AAAAAA

   
Results: 1-15 |
Results: 15
Characterization of the functional heterologous desensitization of hypothalamic 5-HT1A receptors after 5-HT2A receptor activation
Authors: Zhang, YH D'Souza, D Raap, DK Garcia, F Battaglia, G Muma, NA Van de Kar, LD
Citation: Yh. Zhang et al., Characterization of the functional heterologous desensitization of hypothalamic 5-HT1A receptors after 5-HT2A receptor activation, J NEUROSC, 21(20), 2001, pp. 7919-7927
5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells
Authors: Van de Kar, LD Javed, A Zhang, YH Serres, F Raap, DK Gray, TS
Citation: Ld. Van De Kar et al., 5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells, J NEUROSC, 21(10), 2001, pp. 3572-3579
Prenatal cocaine exposure potentiates 5-HT2A receptor function in male andfemale rat offspring
Authors: Battagli, G Cabrera-Vera, TM Van de Kar, LD
Citation: G. Battagli et al., Prenatal cocaine exposure potentiates 5-HT2A receptor function in male andfemale rat offspring, SYNAPSE, 35(3), 2000, pp. 163-172
Low dose zolmitriptan as a 5-HT neuroendocrine challenge agent in humans
Authors: Moeller, FG Bjork, JM Dougherty, DM Van de Kar, LD Marsh, DM Swann, AC
Citation: Fg. Moeller et al., Low dose zolmitriptan as a 5-HT neuroendocrine challenge agent in humans, PSYCHONEURO, 25(6), 2000, pp. 607-618
Chronic clomipramine alters presynaptic 5-HT1B and postsynaptic 5-HT1A receptor sensitivity in rat hypothalamus and hippocampus, respectively
Authors: Newman, ME Gur, E Dremencov, E Garcia, F Lerer, B Van de Kar, LD
Citation: Me. Newman et al., Chronic clomipramine alters presynaptic 5-HT1B and postsynaptic 5-HT1A receptor sensitivity in rat hypothalamus and hippocampus, respectively, NEUROPHARM, 39(12), 2000, pp. 2309-2317
Estrogen desensitizes 5-HT1A receptors and reduces levels of G(z), G(i1) and G(i3) proteins in the hypothalamus
Authors: Raap, DK DonCarlos, L Garcia, F Muma, NA Wolf, WA Battaglia, G Van de Kar, LD
Citation: Dk. Raap et al., Estrogen desensitizes 5-HT1A receptors and reduces levels of G(z), G(i1) and G(i3) proteins in the hypothalamus, NEUROPHARM, 39(10), 2000, pp. 1823-1832
Coadministration of 5-hydroxytryptamine(1A) antagonist WAY-100635 preventsfluoxetine-induced desensitization of postsynaptic 5-hydroxytryptamine(1A)receptors in hypothalamus
Authors: Serres, F Muma, NA Raap, DK Garcia, F Battaglia, G Van de Kar, LD
Citation: F. Serres et al., Coadministration of 5-hydroxytryptamine(1A) antagonist WAY-100635 preventsfluoxetine-induced desensitization of postsynaptic 5-hydroxytryptamine(1A)receptors in hypothalamus, J PHARM EXP, 294(1), 2000, pp. 296-301
Long-term fluoxetine produces behavioral anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats
Authors: Zhang, YH Raap, DK Garcia, F Serres, F Ma, Q Battaglia, G Van de Kar, LD
Citation: Yh. Zhang et al., Long-term fluoxetine produces behavioral anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats, BRAIN RES, 855(1), 2000, pp. 58-66
Low doses of ipsapirone increase growth hormone but not oxytocin secretionin normal male and female subjects
Authors: Newman, ME Li, Q Gelfin, Y Van de Kar, LD Lerer, B
Citation: Me. Newman et al., Low doses of ipsapirone increase growth hormone but not oxytocin secretionin normal male and female subjects, PSYCHOPHAR, 145(1), 1999, pp. 99-104
D-fenfluramine induces serotonin-mediated Fos expression in corticotropin-releasing factor and oxytocin neurons of the hypothalamus, and serotonin-independent Fos expression in enkephalin and neurotensin neurons of the amygdala
Authors: Javed, A Kamradt, MC Van de Kar, LD Gray, TS
Citation: A. Javed et al., D-fenfluramine induces serotonin-mediated Fos expression in corticotropin-releasing factor and oxytocin neurons of the hypothalamus, and serotonin-independent Fos expression in enkephalin and neurotensin neurons of the amygdala, NEUROSCIENC, 90(3), 1999, pp. 851-858
Forebrain pathways mediating stress-induced hormone secretion
Authors: Van de Kar, LD Blair, ML
Citation: Ld. Van De Kar et Ml. Blair, Forebrain pathways mediating stress-induced hormone secretion, FRONT NEURO, 20(1), 1999, pp. 1-48
Selective serotonin reuptake inhibitors and neuroendocrine function
Authors: Raap, DK Van de Kar, LD
Citation: Dk. Raap et Ld. Van De Kar, Selective serotonin reuptake inhibitors and neuroendocrine function, LIFE SCI, 65(12), 1999, pp. 1217-1235
Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT1A binding sites in 5-HT transporter knockout mice
Authors: Li, Q Wichems, C Heils, A Van de Kar, LD Lesch, KP Murphy, DL
Citation: Q. Li et al., Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT1A binding sites in 5-HT transporter knockout mice, J PHARM EXP, 291(3), 1999, pp. 999-1007
Sustained desensitization of hypothalamic 5-hydroxytryptamine(1A) receptors after discontinuation of fluoxetine: Inhibited neuroendocrine responses to 8-hydroxy-2-(dipropylamino)tetralin in the absence of changes in G(i/o/z)proteins
Authors: Raap, DK Garcia, F Muma, NA Wolf, WA Battaglia, G Van de Kar, LD
Citation: Dk. Raap et al., Sustained desensitization of hypothalamic 5-hydroxytryptamine(1A) receptors after discontinuation of fluoxetine: Inhibited neuroendocrine responses to 8-hydroxy-2-(dipropylamino)tetralin in the absence of changes in G(i/o/z)proteins, J PHARM EXP, 288(2), 1999, pp. 561-567
Daily injections of fluoxetine induce dose-dependent desensitization of hypothalamic 5-HT1A receptors: Reductions in neuroendocrine responses to 8-OH-DPAT and in levels of G(z) and G(i) proteins
Authors: Raap, DK Evans, S Garcia, F Li, Q Muma, NA Wolf, WA Battaglia, G Van de Kar, LD
Citation: Dk. Raap et al., Daily injections of fluoxetine induce dose-dependent desensitization of hypothalamic 5-HT1A receptors: Reductions in neuroendocrine responses to 8-OH-DPAT and in levels of G(z) and G(i) proteins, J PHARM EXP, 288(1), 1999, pp. 98-106
Risultati: 1-15 |